WA
LMAT icon

Whipplewood Advisors’s LeMaitre Vascular LMAT Stock Holding History

Whipplewood Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57
Closed -$6.22K – 884
2026
Q1 		$6.22K Buy
+57
New +$5.43K ﹤0.01% 571
2025
Q3 		– Sell
-57
Closed -$4.73K – 793
2025
Q2 		$4.73K Buy
57
+30
+111% +$2.51K ﹤0.01% 703
2025
Q1 		$4.78K Sell
27
-18
-40% -$1.67K ﹤0.01% 708
2024
Q4 		$4.15K Buy
+45
New +$4.33K ﹤0.01% 732

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Whipplewood Advisors's LMAT Position: Q2 2026 in Review

Whipplewood Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 57 shares — an estimated $6.22K sold.

Whipplewood Advisors first reported a position in LMAT in Q4 2024 and held it in 4 quarters. The position peaked at $6.22K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Whipplewood Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Whipplewood Advisors sold 57 LeMaitre Vascular shares in Q2 2026, an estimated $6.22K.
  • Whipplewood Advisors first reported a position in LeMaitre Vascular in Q4 2024 and held it in 4 quarters.
  • Whipplewood Advisors's LeMaitre Vascular position peaked at $6.22K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.